In summary, by analyzing the correlation between T cell inhibitory receptor co-expression and the expression profiles of several other inhibitory receptors, we comprehensively evaluated the pattern of immune checkpoint receptors on peripheral CD8+ T cells in patients with NPC to more effectively guide the selection of inhibitors against immune checkpoint receptors for combination therapies. This evidence concerns the gene CD8A and nasopharyngeal carcinoma.